Abiopharma

🔍 Flatt Stephen Fowler (Director)

Company: NATIONAL HEALTHCARE CORP (NHC)

Report Date: 2026-03-12

Detailed Transactions and Holdings:

• Acquired 1,853 shares of Common Stock at $53.94 per share (Direct)
  Date: 2026-03-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 65,505.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 6,147 shares of Option to Purchase Common Stock at $53.94 per share (Derivative)
  Date: 2026-03-12 | Code: M | Expires: 2028-03-08 | Exercise: 2024-03-08 | equity_swap_involved: 0 | shares_owned_after: 4,294.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 10,000 shares of Option to Purchase Common Stock at $94.1 per share (Derivative)
  Date: 2026-03-12 | Code: H | Expires: 2029-03-05 | Exercise: 2025-03-05 | shares_owned_after: 10,000.00
• Holds 13,000 shares of Option to Purchase Common Stock at $90.62 per share (Derivative)
  Date: 2026-03-12 | Code: H | Expires: 2030-02-28 | Exercise: 2026-02-28 | shares_owned_after: 13,000.00
• Holds 20,000 shares of Option to Purchase Common Stock at $157.13 per share (Derivative)
  Date: 2026-03-12 | Code: H | Expires: 2031-02-23 | Exercise: 2027-02-23 | shares_owned_after: 20,000.00

Footnotes:

• F1: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).